[Neuromuscular blockade due to intravenous amikacine and intrathecal baclofen].
Fernández-Miera
Manuel F
MF
Prado-Vizcardo
María
M
Otero-Fernández
Ana
A
D000368:Aged; D000583:Amikacin / Q000008:administration & dosage / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001418:Baclofen / Q000008:administration & dosage / Q000627:therapeutic use*; D018755:GABA Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D007278:Injections, Spinal; D035002:Lower Extremity / Q000503:physiopathology; D008297:Male; D019148:Neuromuscular Blockade / Q000379:methods*; D010291:Paresis / Q000188:drug therapy* / Q000503:physiopathology; D034941:Upper Extremity / Q000503:physiopathology
D000900:Anti-Bacterial Agents; D018755:GABA Agonists; D000583:Amikacin; D001418:Baclofen